Biolinerx Ltd (BLRX) Annual Balance Sheets

Annual · GAAP · USD millions
Access BLRX quarterly Balance Sheets →
Quarterly balance sheet trends provide context on Biolinerx Ltd's liquidity, leverage, and long-term financial structure.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash And Cash Equivalents3.25
Cash & Short-term Investments3.00
Inventories2.15
Other Current Assets18.28
Total Current Assets23.68
Equipment/Property/Plant Net0.16
Intangible Assets16.37
Other Assets, Noncurrent17.06
Shortterm Investments Classified As Cash Equivalents17.63
Current Prepaid Expenses0.20
Other Current Receivables0.41
Intangible Assets Other Than Goodwill16.37
Noncurrent Assets17.22
Total Assets40.91
Liabilities
Other Liabilities, Current12.12
Total Current Liabilities12.12
Total Long-term Debt0.00
Other liabilities, Noncurrent5.44
NoncurrentLiabilities5.44
Total Liabilities17.56
Stockholders' Equity
Other Equity23.35
Common Stockholder's Equity23.35
Total Stockholder's Equity23.35
Liabilities & Stockholder's Equity40.91
4 historic quarters locked

Sign in to unlock the full Biolinerx Ltd balance sheet history.

About Biolinerx Ltd Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 20-F (Period: 20251231)
  • Filed with the SEC: March 23, 2026
  • Source: zk2634707.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001178913-26-001581

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License